GYRE stock

Gyre Therapeutics Inc. (GYRE) valuation · rev $116.6M

Gyre Therapeutics Inc. (GYRE) rev $116.6M.

Cached valuation scalars
MetricValue
Market cap$589.9M
Revenue$116.6M
P/S5.1
P/B5.8
These valuation metrics as JSON? API free 100/day

GYRE valuation FAQ

What is GYRE's market cap?

Gyre Therapeutics Inc. (GYRE) market cap is $589.9M on the latest cached fundamentals snapshot.

What is GYRE's latest revenue?

Latest cached Gyre Therapeutics Inc. (GYRE) revenue was $116.6M. Statements: https://lician.com/financials/gyre

What is GYRE's price-to-sales ratio?

Gyre Therapeutics Inc. (GYRE) price-to-sales (P/S) is 5.1, cached market cap $589.9M divided by revenue $116.6M.

What is GYRE's price-to-book ratio?

Gyre Therapeutics Inc. (GYRE) price-to-book (P/B) is 5.8 on the latest cached fundamentals snapshot.

How many GYRE valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Gyre Therapeutics Inc. (GYRE): Market cap, Revenue, P/S, and P/B.

Where is GYRE valuation listed?

Cached valuation multiples for Gyre Therapeutics Inc. (GYRE) are listed at https://lician.com/valuation/gyre.

Not investment advice. Cached rows, not a live tape.